Prospective longitudinal comparison study of surgical therapies for peri-implantitis: 3-year follow-up.


Journal

Australian dental journal
ISSN: 1834-7819
Titre abrégé: Aust Dent J
Pays: Australia
ID NLM: 0370612

Informations de publication

Date de publication:
09 2019
Historique:
accepted: 02 04 2019
pubmed: 9 4 2019
medline: 4 3 2020
entrez: 9 4 2019
Statut: ppublish

Résumé

The aim of this study was to compare different surgical therapies to treat peri-implantitis. Twenty-three patients presenting one implant affected by peri-implantitis were divided into three groups: (i) open flap debridement (OFD) and citric acid decontamination (CAD); (ii) OFD, CAD and subepithelial connective tissue graft (SCTG); (iii) OFD, CAD and implantoplasty. Modified plaque index (MPI), gingival bleeding index (GBI), keratinized mucosa (KM) width, probing depth (PD), bleeding or suppuration on probing (B/SOP), and radiographic crestal bone level were registered 1(T1), 2(T2) and 3(T3) years after treatment. In Group 1 there was a significant improvement in MPI from baseline to T1, and a significant reduction in PD over time. In Group 2, none of the assessed clinical parameters showed any statistically significant variation over time. In Group 3, there was a significant decrease in PD and B/SOP over time. When comparing the 3 Groups, KM was significanlty greater in Group 2 vs. Group 1 and Group 3 at T1 and T2, and in Group 2 vs. Group 3 at T3. All therapies were successful in the management of peri-implantitis; however, SCTG maintained the greatest KM width. Surgical therapies combined with mechanical and chemical decontamination contributed to peri-implant tissue health.

Sections du résumé

BACKGROUND
The aim of this study was to compare different surgical therapies to treat peri-implantitis.
METHODS
Twenty-three patients presenting one implant affected by peri-implantitis were divided into three groups: (i) open flap debridement (OFD) and citric acid decontamination (CAD); (ii) OFD, CAD and subepithelial connective tissue graft (SCTG); (iii) OFD, CAD and implantoplasty. Modified plaque index (MPI), gingival bleeding index (GBI), keratinized mucosa (KM) width, probing depth (PD), bleeding or suppuration on probing (B/SOP), and radiographic crestal bone level were registered 1(T1), 2(T2) and 3(T3) years after treatment.
RESULTS
In Group 1 there was a significant improvement in MPI from baseline to T1, and a significant reduction in PD over time. In Group 2, none of the assessed clinical parameters showed any statistically significant variation over time. In Group 3, there was a significant decrease in PD and B/SOP over time. When comparing the 3 Groups, KM was significanlty greater in Group 2 vs. Group 1 and Group 3 at T1 and T2, and in Group 2 vs. Group 3 at T3.
CONCLUSION
All therapies were successful in the management of peri-implantitis; however, SCTG maintained the greatest KM width. Surgical therapies combined with mechanical and chemical decontamination contributed to peri-implant tissue health.

Identifiants

pubmed: 30958567
doi: 10.1111/adj.12693
doi:

Substances chimiques

Dental Implants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-245

Informations de copyright

© 2019 Australian Dental Association.

Références

Smeets R, Henningsen A, Jung O, Heiland M, Hammächer C, Stein JM. Definition, etiology, prevention and treatment of peri-implantitis-a review. Head Face Med 2014;10:34.
Albrektsson T, Buser D, Chen ST, et al. Statements from the Estepona consensus meeting on peri-implantitis, February 2-4, 2012. Clin Implant Dent Relat Res 2012;14:781-782.
Romeo E, Ghisolfi M, Murgolo N, Chiapasco M, Lops D, Vogel G. Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part I: clinical outcome. Clin Oral Implants Res 2005;16:9-18.
de Waal YCM, Raghoebar GM, Huddleston Slater JJ, Meijer HJ, Winkel EG, van Winkelhoff AJ. Implant decontamination during surgical peri-implantitis treatment: a randomized, double-blind, placebo-controlled trial. J Clin Periodontol 2013;40:186-195.
Renvert S, Polyzois I. Treatment of pathologic peri-implant pockets. Periodontol 2000 2018;76:180-190.
Schwarz F, John G, Mainusch S, Sahm N, Becker J. Combined surgical therapy of peri-implantitis evaluating two methods of surface debridement and decontamination. A two-year clinical follow up report. J Clin Periodontol 2012;39:789-797.
Schwarz F, Herten M, Sager M, Bieling K, Sculean A, Becker J. Comparison of naturally occurring and ligature-induced peri-implantitis bone defects in humans and dogs. Clin Oral Implants Res 2007;18:161-170.
Lindhe J, Meyle J; Group DoEWoP. Peri-implant diseases: consensus report of the sixth european workshop on periodontology. J Clin Periodontol 2008;35:282-285.
Renvert S, Polyzois I, Claffey N. Surgical therapy for the control of peri-implantitis. Clin Oral Implants Res 2012;23(S6):84-94.
Schwarz F, Bieling K, Latz T, Nuesry E, Becker J. Healing of intrabony peri-implantitis defects following application of a nanocrystalline hydroxyapatite (Ostim) or a bovine-derived xenograft (Bio-Oss) in combination with a collagen membrane (Bio-Gide). A case series. J Clin Periodontol 2006;33:491-499.
Behneke A, Behneke N, d'Hoedt B. Treatment of peri-implantitis defects with autogenous bone grafts: six-month to 3-year results of a prospective study in 17 patients. Int J Oral Maxillofac Implants 2000;15:125-138.
Schwarz F, Sahm N, Becker J. Combined surgical therapy of advanced peri-implantitis lesions with concomitant soft tissue volume augmentation. A case series. Clin Oral Implants Res 2014;25:132-136.
Khoury F, Buchmann R. Surgical therapy of peri-implant disease: a 3-year follow-up study of cases treated with 3 different techniques of bone regeneration. J Periodontol 2001;72:1498-1508.
Esposito M, Grusovin MG, Worthington HV. Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review Eur J Oral Implantol 2012;5:S21-S41.
Romeo E, Lops D, Chiapasco M, Ghisolfi M, Vogel G. Therapy of peri-implantitis with resective surgery. A 3-year clinical trial on rough screw-shaped oral implants. Part II: radiographic outcome. Clin Oral Implants Res 2007;18:179-187.
Schwarz F, Sahm N, Iglhaut G, Becker J. Impact of the method of surface debridement and decontamination on the clinical outcome following combined surgical therapy of peri-implantitis: a randomized controlled clinical study. J Clin Periodontol 2011;38:276-284.
Parma-Benfenati S, Roncati M, Tinti C. Treatment of peri-implantitis: surgical therapeutic approaches based on peri-implantitis defects. Int J Periodontics Restorative Dent 2013;33:627-633.
Reino DM, Novaes AB Jr, Grisi MF, Maia LP, de Souza SL. Palatal harvesting technique modification for better control of the connective tissue graft dimensions. Braz Dent J 2013;24:565-568.
Pommer B, Haas R, Mailath-Pokorny G, et al. Periimplantitis treatment: long-term comparison of laser decontamination and implantoplasty surgery. Implant Dent 2016;25:646-649.
Mombelli A, van Oosten MA, Schurch E Jr, Land NP. The microbiota associated with successful or failing osseointegrated titanium implants. Oral Microbiol Immunol 1987;2:145-151.
Mangano FG, Shibli JA, Sammons RL, Iaculli F, Piattelli A, Mangano C. Short (8-mm) locking-taper implants supporting single crowns in posterior region: a prospective clinical study with 1-to 10-years of follow-up. Clin Oral Impl Res 2014;25:933-940.
Heitz-Mayfield LJA, Salvi GE, Mombelli A, et al. Supportive peri-implant therapy following anti-infective surgical peri-implantitis treatment: 5-year survival and success. Clin Oral Impl Res 2018;29:1-6.
Ata-Ali J, Candel-Marti ME, Flichy-Fernandez AJ, Penarrocha-Oltra D, Balaguer-Martinez JF, Penarrocha DM. Peri-implantitis: associated microbiota and treatment. Med Oral Patol Oral Cir Bucal 2011;16:e937-e943.
Mahato N, Wu X, Wang L. Management of peri-implantitis: a systematic review, 2010-2015. Springerplus 2016;5:105.
Gustumhaugen E, Lönn-Stensrud J, Scheie AA, Lyngstadaas SP, Ekfeldt A, Taxt-Lamolle S. Effect of chemical and mechanical debridement techniques on bacterial re-growth on rough titanium surfaces: an in vitro study. Clin Oral Implants Res 2014;25:707-713.
Carcuac O, Derks J, Charalampakis G, Abrahamsson I, Wennström J, Berglundh T. Adjunctive systemic and local antimicrobial therapy in the surgical treatment of peri-implantitis: a randomized controlled clinical trial. J Dent Res 2016;95:50-57.
Htet M, Madi M, Zakaria O, et al. Decontamination of anodized implant surface with different modalities for peri-implantitis treatment: lasers and mechanical debridement with citric acid. J Periodontol 2016;87:953-961.
Valderrama P, Blansett JA, Gonzalez MG, Cantu MG, Wilson TG. Detoxification of implant surfaces affected by peri-implant disease: an overview of non-surgical methods. Open Dent J 2014;8:77-84.
Gamal AY, Abdel-Ghaffar KA, Iacono VJ. A novel approach for enhanced nanoparticle-sized bone substitute adhesion to chemically treated peri-implantitis-affected implant surfaces: an in vitro proof-of-principle study. J Periodontol 2013;84:239-247.
Wood DL, Hoag PM, Donnenfeld OW, Rosenfeld LD. Alveolar crest reduction following full and partial thickness flaps. J Periodontol 1972;43:141-144.
Thoma DS, Naenni N, Figuero E, et al. Effects of soft tissue augmentation procedures on peri-implant health or disease: a systematic review and meta-analysis. Clin Oral Implants Res 2018;29(Suppl 15):32-49.
Pranskunas M, Poskevicius L, Juodzbalys G, Kubilius R, Jimbo R. Influence of peri-implant soft tissue condition and plaque accumulation on peri-implantitis: a systematic review. J Oral Maxillofac Res 2016;7:e2.
Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol 2018;89:S267-S290.
Renvert S, Polyzois IN. Clinical approaches to treat peri-implant mucositis and peri-implantitis. Periodontol 2000 2015;68:369-404.

Auteurs

H R Dalago (HR)

Private Practice, Florianópolis, SC, Brazil.

V Perrotti (V)

Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.

S F Torres de Freitas (SF)

Health Public Department, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

C F Ferreira (CF)

University of Tennessee Health Sciences, Memphis, Tennessee, USA.

A Piattelli (A)

Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.

F Iaculli (F)

Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.

M A Bianchini (MA)

Department of Periodontology, Federal University of Santa Catarina, Florianópolis, SC, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH